Literature DB >> 15059133

The best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?

João Paulo Vieira Pinheiro1, Joachim Boos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15059133     DOI： 10.1111/j.1365-2141.2004.04863.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  12 in total

1.  A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase.

Authors:  Naina Patel; Shekhar Krishnan; Marc N Offman; Marcin Krol; Catherine X Moss; Carly Leighton; Frederik W van Delft; Mark Holland; Jizhong Liu; Seema Alexander; Clare Dempsey; Hany Ariffin; Monika Essink; Tim O B Eden; Colin Watts; Paul A Bates; Vaskar Saha
Journal:  J Clin Invest       Date:  2009-06-08       Impact factor: 14.808

Review 2.  Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.

Authors:  Ritsuro Suzuki
Journal:  Int J Hematol       Date:  2010-12-01       Impact factor: 2.490

3.  Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.

Authors:  Benjamin K Tomlinson; James A Thomson; John S Bomalaski; Monica Diaz; Taiwo Akande; Nichole Mahaffey; Tianhong Li; Mrinal P Dutia; Karen Kelly; I-Yeh Gong; Thomas Semrad; David R Gandara; Chong-Xian Pan; Primo N Lara
Journal:  Clin Cancer Res       Date:  2015-03-04       Impact factor: 12.531

4.  Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine.

Authors:  Ehsan A Ehsanipour; Xia Sheng; James W Behan; Xingchao Wang; Anna Butturini; Vassilios I Avramis; Steven D Mittelman
Journal:  Cancer Res       Date:  2013-04-12       Impact factor: 12.701

5.  Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase.

Authors:  Tawnya L Bowles; Randie Kim; Joseph Galante; Colin M Parsons; Subbulakshmi Virudachalam; Hsing-Jien Kung; Richard J Bold
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

6.  Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells.

Authors:  Tadayuki Akagi; Dong Yin; Norihiko Kawamata; Claus R Bartram; Wolf-K Hofmann; Jee Hoon Song; Carl W Miller; Monique L den Boer; H Phillip Koeffler
Journal:  Leuk Res       Date:  2008-12-02       Impact factor: 3.156

7.  Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia.

Authors:  Inge van der Sluis; Anja Möricke; Gabriele Escherich; Arend von Stackelberg; Wolfgang Holter; Thomas Klingebiel; Christian Flotho; Sabine Legien; Wim Tissing; Marc Bierings; Cecile Guimbal-Schmolck; Uwe Pichlmeier; Hans-Jürgen Kühnel; Rob Pieters
Journal:  Haematologica       Date:  2013-06-10       Impact factor: 9.941

8.  Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase.

Authors:  L G Feun; A Marini; G Walker; G Elgart; F Moffat; S E Rodgers; C J Wu; M You; M Wangpaichitr; M T Kuo; W Sisson; A A Jungbluth; J Bomalaski; N Savaraj
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

9.  Clinical utility of ammonia concentration as a diagnostic test in monitoring of the treatment with L-asparaginase in children with acute lymphoblastic leukemia.

Authors:  Małgorzata Czogała; Walentyna Balwierz; Krystyna Sztefko; Iwona Rogatko
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

10.  Increased expression of argininosuccinate synthetase protein predicts poor prognosis in human gastric cancer.

Authors:  Yan-Shen Shan; Hui-Ping Hsu; Ming-Derg Lai; Meng-Chi Yen; Yi-Pey Luo; Yi-Ling Chen
Journal:  Oncol Rep       Date:  2014-10-20       Impact factor: 3.906
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.